Assure Holdings Corp.

OTCPK:IONM Voorraadrapport

Marktkapitalisatie: US$385.5k

Assure Holdings Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Assure Holdings's earnings have been declining at an average annual rate of -38.3%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been declining at an average rate of 31.7% per year.

Belangrijke informatie

-38.3%

Groei van de winst

0.04%

Groei van de winst per aandeel

Healthcare Groei van de industrie8.5%
Inkomstengroei-31.7%
Rendement op eigen vermogenn/a
Nettomarge519.8%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Assure Holdings stock gains on proposed public offering of common stock

Aug 22

Assure Holdings to continue streamlining business to achieve positive operating cash flow

Jul 14

Assure Holdings announces partnership with Hayden IR

Jul 06

Investors Are Unsure About Assure, But I Am Not

Feb 17

Opbrengsten en kosten

Hoe Assure Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

OTCPK:IONM Opbrengsten, kosten en inkomsten (USD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24-4-22120
31 Mar 24-4-23140
31 Dec 23-4-21140
30 Sep 23-1-26140
30 Jun 23-1-24140
31 Mar 23-5-24140
31 Dec 22-1-23150
30 Sep 2210-10160
30 Jun 2218-6160
31 Mar 2229-4170
31 Dec 2129-3160
30 Sep 2125-3150
30 Jun 2121-4140
31 Mar 214-16120
31 Dec 204-15110
30 Sep 20-7-21100
30 Jun 20-3-17100
31 Mar 20161100
31 Dec 19183100
30 Sep 1919490
30 Jun 1918480
31 Mar 1915370
31 Dec 1815460
30 Sep 1823-1200
30 Jun 1820-2210
31 Mar 1818-5210
31 Dec 1716-6200
30 Sep 1715640
30 Jun 1713530
31 Mar 179620
31 Dec 166410

Kwaliteitswinsten: IONM is currently unprofitable.

Groeiende winstmarge: IONM is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: IONM is unprofitable, and losses have increased over the past 5 years at a rate of 38.3% per year.

Versnelling van de groei: Unable to compare IONM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: IONM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).


Rendement op eigen vermogen

Hoge ROE: IONM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden